Sexual dysfunction

Jump to: navigation, search
Sexual dysfunction
ICD-10 F52
ICD-9 302.7

WikiDoc Resources for Sexual dysfunction

Articles

Most recent articles on Sexual dysfunction

Most cited articles on Sexual dysfunction

Review articles on Sexual dysfunction

Articles on Sexual dysfunction in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Sexual dysfunction

Images of Sexual dysfunction

Photos of Sexual dysfunction

Podcasts & MP3s on Sexual dysfunction

Videos on Sexual dysfunction

Evidence Based Medicine

Cochrane Collaboration on Sexual dysfunction

Bandolier on Sexual dysfunction

TRIP on Sexual dysfunction

Clinical Trials

Ongoing Trials on Sexual dysfunction at Clinical Trials.gov

Trial results on Sexual dysfunction

Clinical Trials on Sexual dysfunction at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Sexual dysfunction

NICE Guidance on Sexual dysfunction

NHS PRODIGY Guidance

FDA on Sexual dysfunction

CDC on Sexual dysfunction

Books

Books on Sexual dysfunction

News

Sexual dysfunction in the news

Be alerted to news on Sexual dysfunction

News trends on Sexual dysfunction

Commentary

Blogs on Sexual dysfunction

Definitions

Definitions of Sexual dysfunction

Patient Resources / Community

Patient resources on Sexual dysfunction

Discussion groups on Sexual dysfunction

Patient Handouts on Sexual dysfunction

Directions to Hospitals Treating Sexual dysfunction

Risk calculators and risk factors for Sexual dysfunction

Healthcare Provider Resources

Symptoms of Sexual dysfunction

Causes & Risk Factors for Sexual dysfunction

Diagnostic studies for Sexual dysfunction

Treatment of Sexual dysfunction

Continuing Medical Education (CME)

CME Programs on Sexual dysfunction

International

Sexual dysfunction en Espanol

Sexual dysfunction en Francais

Business

Sexual dysfunction in the Marketplace

Patents on Sexual dysfunction

Experimental / Informatics

List of terms related to Sexual dysfunction

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]

Overview

Sexual dysfunction or sexual malfunction (see also sexual function) is difficulty during any stage of the sexual act (which includes desire, arousal, orgasm, and resolution) that prevents the individual or couple from enjoying sexual activity.

Onset

Emotional factors affecting sex include both interpersonal problems (such as marital/relationship problems, or lack of trust and open communication between partners) and psychological problems within the individual (depression, sexual fears or guilt, past sexual trauma, sexual disorders,[1] and so on).

Physical factors include drugs (alcohol, nicotine, narcotics, stimulants, antihypertensives, antihistamines, and some psychotherapeutic drugs); injuries to the back, problems with an enlarged prostate gland, problems with blood supply, nerve damage (as in spinal cord injuries); or disease (diabetic neuropathy, multiple sclerosis, tumors, and, rarely, tertiary syphilis); failure of various organ systems (such as the heart and lungs); endocrine disorders (thyroid, pituitary, or adrenal gland problems); hormonal deficiencies (low testosterone, estrogen, or androgens); and some birth defects.

Classification

Sexual dysfunction disorders are generally classified into four categories: sexual desire disorders, sexual arousal disorders, orgasm disorders, and sexual pain disorders.

  1. Sexual desire disorders or decreased libido can be caused by a decrease in normal estrogen (in women) or testosterone (in both men and women) production. Other causes may be aging, fatigue, pregnancy, medications (such as the SSRIs) or psychiatric conditions, such as depression and anxiety. Loss of libido from SSRIs usually reverses after SSRIs are discontinued, but in some cases it does not. This is known as PSSD.
  2. Sexual arousal disorders were previously known as frigidity in women and impotence in men, though these have now been replaced with less judgmental terms. Impotence is now known as erectile dysfunction, and frigidity has been replaced with a number of terms describing specific problems with, for example, desire or arousal.
    For both men and women, these conditions can manifest as an aversion to, and avoidance of, sexual contact with a partner. In men, there may be partial or complete failure to attain or maintain an erection, or a lack of sexual excitement and pleasure in sexual activity.
    There may be medical causes to these disorders, such as decreased blood flow or lack of vaginal lubrication. Chronic disease can also contribute, as well as the nature of the relationship between the partners. As the success of sildenafil (Viagra) attests, most erectile disorders in men are primarily physical, not psychological conditions.
  3. Orgasm disorders are a persistent delay or absence of orgasm following a normal sexual excitement phase. The disorder can occur in both women and men. Again, the SSRI antidepressants are frequent culprits -- these can delay the achievement of orgasm or eliminate it entirely.
  4. Sexual pain disorders affect women almost exclusively and are known as dyspareunia (painful intercourse) and vaginismus (an involuntary spasm of the muscles of the vaginal wall that interferes with intercourse). Dyspareunia may be caused by insufficient lubrication (vaginal dryness) in women.

Poor lubrication may result from insufficient excitement and stimulation, or from hormonal changes caused by menopause, pregnancy, or breast-feeding. Irritation from contraceptive creams and foams can also cause dryness, as can fear and anxiety about sex.

It is unclear exactly what causes vaginismus, but it is thought that past sexual trauma (such as rape or abuse) may play a role. Another female sexual pain disorder is called vulvodynia or vulvar vestibulitis. In this condition, women experience burning pain during sex which seems to be related to problems with the skin in the vulvar and vaginal areas. The cause is unknown.

Sexual dysfunctions are more common in the early adult years, with the majority of people seeking care for such conditions during their late twenties through thirties. The incidence increases again in the geriatric population, typically with gradual onset of symptoms that are associated most commonly with medical causes of sexual dysfunction.

Sexual dysfunction is more common in people who abuse alcohol and drugs. It is also more likely in people suffering from diabetes and degenerative neurological disorders. Ongoing psychological problems, difficulty maintaining relationships or chronic disharmony with the current sexual partner can also interfere with sexual function.

Differential Diagnosis of Male Hypoactive Sexual Desire Disorder

  • Another medical condition
  • lnterpersonal factors
  • Severe relationship distress
  • Nonsexual mental disorders
  • Other sexual dysfunctions
  • Substance/medication use[2]

Risk Factors of Male Hypoactive Sexual Desire Disorder

  • Age
  • Attitudes
  • Alcohol
  • Anxiety
  • Emotional connection
  • Hypogonadism
  • Hyperprolactinemia
  • Interpersonal problems
  • Lack of adequate sex education
  • Mood
  • Man's feelings about himself
  • Partner's sexual desire
  • Social and cultural contextual factors
  • Trauma from early life experiences[2]

Diagnosis

Symptoms

Psychological sexual disorders

The fourth edition of the Diagnostic and Statistical Manual of Mental Disorders lists the following psychological sexual disorders:

Other sexual problems

Other related problems

Diagnostic Criteria

DSM-V Diagnostic Criteria for Male Hypoactive Sexual Desire Disorder [2]

  • A. Persistently or recurrently deficient (or absent) sexual/erotic thoughts or fantasies and desire for sexual activity. The judgment of deficiency is made by the clinician, taking into account factors that affect sexual functioning, such as age and general and socio cultural contexts of the individual’s life.

AND

  • B. The symptoms in Criterion A have persisted for a minimum duration of approximately 6 months.

AND

  • C. The symptoms in Criterion A cause clinically significant distress in the individual.

AND

  • D. The sexual dysfunction is not better explained by a nonsexual mental disorder or as a consequence of severe relationship distress or other significant stressors and is not attributable to the effects of a substance/medication or another medical condition.


Specify whether:

  • Lifelong: The disturbance has been present since the Individual became sexually active.
  • Acquired; The disturbance began after a period of relatively normal sexual function.

Specify whether:

  • Generaiized: Not limited to certain types of stimulation, situations, or partners.
  • Situational: Only occurs with certain types of stimulation, situations, or partners.

Specify current severity:

  • Mild: Evidence of mild distress over the symptoms in Criterion A.
  • Moderate: Evidence of moderate distress over the symptoms In Criterion A.
  • Severe: Evidence of severe or extreme distress over the symptoms in Criterion A.

Clinical studies

Since people tend not to talk to one another about their sexual problems, many people imagine that they are "abnormal", or that their sexual problems are unique or shameful. Images of sexuality presented by society and the media often present people with unrealistic ideals of sexual behavior, whether of the ideals of chastity and sexual fidelity presented by religion, or the ideal of sexual inexhaustibility and promiscuous availability presented by pornography. Neither image appears to be representative of human behavior in real life: this has been summed up in the phrase "everyone lies about sex".

The earliest attempts at treating sexual dysfunctions, especially erectile dysfunction, date back to Muslim physicians and pharmacists in the medieval Islamic world. They were the first to prescribe medication for the treatment of this problem, and they developed several methods of therapy for this issue, including a single-drug therapy method where a drug was prescribed and a "combination method of either a drug or food." Most of these drugs were oral medication, though a few patients were also treated through topical and transurethral means. Sexual dysfunctions were being treated with clinically tested drugs in the Islamic world since the 9th century until the 16th century by a number of Muslim physicians and pharmacists, including Muhammad ibn Zakarīya Rāzi, Thabit bin Qurra, Ibn Al-Jazzar, Avicenna (The Canon of Medicine), Averroes, Ibn al-Baitar, and Ibn al-Nafis (The Comprehensive Book on Medicine).[3]

In modern times, the genuine clinical study of sexual problems is usually dated back no further than 1970 when Masters and Johnson's Human Sexual Inadequacy was published. It was the result of over a decade of work at the Reproductive Biology Research Foundation in St. Louis, involving 790 cases. The work grew from Masters and Johnson's earlier Human Sexual Response (1966).

Prior to Masters and Johnson the clinical approach to sexual problems was largely derived from the thinking of Freud. It was held with psychopathology and approached with a certain pessimism regarding the chance of help or improvement. Sexual problems were merely symptoms of a deeper malaise and the diagnostic approach was from the psychopathological. There was little distinction between difficulties in function and variations nor between perversion and problems. Despite work by psychotherapists such as Balint sexual difficulties were crudely split into frigidity or impotence, terms which too soon acquired negative connotations in popular culture.

The achievement of Human Sexual Inadequacy was to move thinking from psychopathology to learning, only if a problem did not respond to educative treatment would psychopathological problems be considered. Also treatment was directed at couples, whereas before partners would be seen individually. Masters and Johnson saw that sex was a joint act. They believed that sexual communication was the key issue to sexual problems not the specifics of an individual problem. They also proposed co-therapy, a matching pair of therapists to the clients, arguing that a lone male therapist could not fully comprehend female difficulties and vice versa.

The basic Masters and Johnson treatment program was an intensive two week program to develop efficient sexual communication. Couple-based and therapist led the program began with discussion and then sensate focus between the couple to develop shared experiences. From the experiences specific difficulties could be determined and approached with a specific therapy. In a limited number of male only cases (41) Masters and Johnson had developed the use of a female surrogate, an approach they soon abandoned over the ethical, legal and other problems it raised.

In defining the range of sexual problems Masters and Johnson defined a boundary between dysfunction and deviations. Dysfunctions were transitory and experience by the majority of people, dysfunctions bounded male primary or secondary impotence, premature ejaculation, ejaculatory incompetence; female primary orgasmic dysfunction and situational orgasmic dysfunction; pain during intercourse (dyspareunia) and vaginismus. According to Masters and Johnson sexual arousal and climax are a normal physiological process of every functionally intact adult, but despite being autonomic it can be inhibited. Masters and Johnson treatment program for dysfunction was 81.1% successful.

Despite the work of Masters and Johnson the field in the US was quickly over-run by ethusiastic rather than systematic approaches, blurring the space between 'enrichment' and therapy. Although it has been argued that the impact of the work was such that it would be impossible to repeat such a clean experiment.

See also

References

  1. Michetti, Paolo Maria (2006). "Male sexuality and regulation of emotions: a study on the association between alexithymia and erectile dysfunction (ED)". International Journal of Impotence Research. 18 (2): 170–174. PMID 16151475. Retrieved 2007-02-02. Unknown parameter |coauthors= ignored (help)
  2. 2.0 2.1 2.2 Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.
  3. A. Al Dayela and N. al-Zuhair (2006), "Single drug therapy in the treatment of male sexual/erectile dysfunction in Islamic medicine", Urology 68 (1), p. 253-254.

Further reading

  • Kaplan, Helen Singer, The New Sex Therapy: Active Treatment Of Sexual Dysfunctions, New York, Brunner/Mazel, 1974. ISBN 0876300832

External links

bs:Poremećaji seksualnog nagona ca:Disfunció sexual de:Sexuelle Dysfunktion is:Kynlífsraskanir



Linked-in.jpg